The United States, which declared a disaster due to the new type of coronavirus (SARS-CoV-2) epidemic, came up with an extraordinary treatment method. The blood of COVID-2019 patients recovering in the country will be transferred to newly diagnosed patients. Experts say this solution is not effective but permanent.
The coronavirus outbreak continues to be common in western countries. The state of emergency, announced in the USA, also caused its citizens to panic. Recent scientific studies on the virus have produced extraordinary results. According to the findings, the blood of individuals who survived COVID-2019 disease caused by the new type of coronavirus SARS-CoV-2 may be hope for new patients.
The scientists who conducted the study will prepare serums based on the blood of people who have survived the new coronavirus. Viral antibodies that will be found in these serums will be injected into other people in the disease process. Thus, protection will be provided in the short term.
The treatment method in question is temporary but its origin dates back to the 19th century:
This method of blood treatment, called “passive antibody” in the medical world, was previously used in broadcast diseases such as polio, mumps, flu and measles, and outbreaks were slowed. John Hopkins University researchers, who have become the source of many researches on the new type of coronavirus, said that antibody therapy can be put into action immediately.
“Using this option does not require any research or development,” said Arturo Casadevall, a study author. As it is known, studies continue in many countries of the world against the new type of coronavirus. However, vaccine and drug development will at best take 10 months. The method of treatment through blood can be applied at least until a permanent solution is found.
So how does this proposed process for coronavirus treatment work?
Patients who have survived or are in the process of circumventing the coronavirus donate their blood to patients who will be treated. In this process, high levels of antibodies produced against SARS-CoV-2 in their bodies are found in the blood taken. These antibodies can circulate in the blood of the survivors for months or even years.
Short-term treatments will be possible if scientists can take and process the antibodies in question. Antibody serums will act as a temporary drug to be injected to high-risk people, healthcare professionals and patient relatives. In fact, people who have never been infected will be able to have a defense system before the virus arrives.
So far, nearly 80 thousand patients have survived the COVID-2019 caused by the new type of coronavirus. John Hopkins University researchers reported that the blood transfer method in question could be implemented within a few weeks or months.